China’s vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue.
Tag Archive for: mRNA vaccine
A combination of Merck’s blockbuster cancer drug Keytruda and an mRNA vaccine from Moderna has demonstrated positive results at the three-year stage in a Phase IIb study of patients with resected high-risk melanoma following complete resection.
Pfizer on Tuesday reported its first quarterly loss since 2019, as demand fell for its COVID products and it recorded a hefty charge mainly from the U.S. government returning millions of doses of its antiviral treatment Paxlovid.
Pfizer’s mRNA vaccine, Comirnaty, was the company’s highest-selling product once again, but leaders are looking to the Seagen acquisition for future growth.
The company stated that its flu vaccine had generated a stronger immune response against all four A and B strains of the virus compared to traditional flu shots in a late-stage trial. Moderna also announced it was scaling down manufacturing of its COVID-19 vaccine, an updated version of which was approved this week by U.S. regulators, to align with lower post-pandemic demand and help the company sooner hit its target of 75% to 80% gross margin growth.
China’s CanSino Biologics, which recently announced a contract manufacturing deal to support AstraZeneca’s messenger RNA (mRNA) technology vaccine program, is in talks with more firms on similar deals, its CEO said, as it seeks new revenue streams to make up for plummeting COVID vaccine demand.
AstraZeneca is China’s largest drugmaker and is doubling down on the world’s No.2 pharmaceutical market amid slumping sales of its COVID vaccine.
Global recruitment for the trial has begun, with the first patients being enrolled in Australia, the companies said, adding that the study would take place in more than 25 countries around the world.
The World Health Organization officially launched its mRNA vaccine technology hub in Cape Town, a facility established during the COVID-19 pandemic to help poorer countries struggling to gain access to life-saving medication.
A U.S. appeals court handed Moderna Inc. a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp. patent related to the companies’ legal fight over Moderna’s blockbuster COVID-19 vaccines.
